tiprankstipranks
Trending News
More News >
Gilead Sciences (IT:1GILD)
:1GILD
Italy Market

Gilead Sciences (1GILD) Ratios

Compare
2 Followers

Gilead Sciences Ratios

IT:1GILD's free cash flow for Q4 2024 was $0.79. For the 2024 fiscal year, IT:1GILD's free cash flow was decreased by $ and operating cash flow was $0.32. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.60 1.43 1.36 1.30 1.39
Quick Ratio
1.45 1.27 1.10 1.06 1.12
Cash Ratio
0.83 0.54 0.48 0.46 0.53
Solvency Ratio
0.01 0.21 0.16 0.18 0.03
Operating Cash Flow Ratio
0.90 0.71 0.81 0.98 0.72
Short-Term Operating Cash Flow Coverage
5.97 4.45 3.99 7.51 2.96
Net Current Asset Value
$ -20.58B$ -23.29B$ -26.73B$ -31.83B$ -34.37B
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.40 0.40 0.39 0.46
Debt-to-Equity Ratio
0.16 1.09 1.19 1.27 1.72
Debt-to-Capital Ratio
0.14 0.52 0.54 0.56 0.63
Long-Term Debt-to-Capital Ratio
0.06 0.50 0.52 0.54 0.61
Financial Leverage Ratio
3.05 2.72 2.98 3.23 3.75
Debt Service Coverage Ratio
0.52 3.37 2.37 3.68 0.68
Interest Coverage Ratio
1.70 8.06 7.84 7.40 7.14
Debt to Market Cap
0.03 0.25 0.23 0.29 0.43
Interest Debt Per Share
3.28 20.78 20.85 22.05 25.76
Net Debt to EBITDA
-4.14 1.80 2.24 1.89 6.15
Profitability Margins
Gross Profit Margin
78.26%76.04%79.26%75.82%81.48%
EBIT Margin
5.80%28.78%24.74%33.98%10.75%
EBITDA Margin
5.78%38.71%32.45%41.49%16.74%
Operating Profit Margin
5.78%28.05%26.87%27.12%28.47%
Pretax Profit Margin
2.40%25.30%21.31%30.32%6.76%
Net Profit Margin
1.67%20.89%16.83%22.80%0.36%
Continuous Operations Profit Margin
1.67%20.70%16.74%22.71%0.36%
Net Income Per EBT
69.57%82.59%78.98%75.20%5.33%
EBT Per EBIT
41.52%90.19%79.32%111.77%23.74%
Return on Assets (ROA)
0.81%9.12%7.27%9.16%0.13%
Return on Equity (ROE)
2.48%24.81%21.65%29.55%0.49%
Return on Capital Employed (ROCE)
3.54%14.96%14.11%13.14%12.33%
Return on Invested Capital (ROIC)
2.36%11.82%10.62%9.59%0.63%
Return on Tangible Assets
1.56%20.71%17.69%23.79%0.33%
Earnings Yield
0.42%5.60%4.26%6.83%0.12%
Efficiency Ratios
Receivables Turnover
6.51 5.82 5.71 6.08 5.05
Payables Turnover
7.50 11.81 6.25 9.36 5.42
Inventory Turnover
3.66 3.64 2.01 2.41 1.52
Fixed Asset Turnover
5.31 5.10 4.98 5.33 4.97
Asset Turnover
0.49 0.44 0.43 0.40 0.36
Working Capital Turnover Ratio
4.80 6.17 7.34 6.94 1.89
Cash Conversion Cycle
107.32 132.21 187.47 172.25 245.56
Days of Sales Outstanding
56.11 62.73 63.91 60.06 72.32
Days of Inventory Outstanding
99.85 100.38 181.95 151.18 240.62
Days of Payables Outstanding
48.64 30.89 58.39 38.98 67.38
Operating Cycle
155.96 163.10 245.86 211.24 312.94
Cash Flow Ratios
Operating Cash Flow Per Share
8.68 6.42 7.23 9.06 6.50
Free Cash Flow Per Share
8.26 5.95 6.65 8.60 5.98
CapEx Per Share
0.42 0.47 0.58 0.46 0.52
Free Cash Flow to Operating Cash Flow
0.95 0.93 0.92 0.95 0.92
Dividend Paid and CapEx Coverage Ratio
2.44 1.82 2.04 2.72 1.99
Capital Expenditure Coverage Ratio
20.70 13.69 12.46 19.66 12.57
Operating Cash Flow Coverage Ratio
3.48 0.32 0.36 0.43 0.26
Operating Cash Flow to Sales Ratio
0.38 0.30 0.33 0.42 0.33
Free Cash Flow Yield
8.95%7.34%7.74%11.85%10.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
239.97 17.85 23.46 14.65 822.84
Price-to-Sales (P/S) Ratio
4.01 3.73 3.95 3.34 2.97
Price-to-Book (P/B) Ratio
5.96 4.43 5.08 4.33 4.02
Price-to-Free Cash Flow (P/FCF) Ratio
11.18 13.62 12.91 8.44 9.74
Price-to-Operating Cash Flow Ratio
10.64 12.63 11.88 8.01 8.97
Price-to-Earnings Growth (PEG) Ratio
-2.62 0.74 -0.90 <0.01 -8.37
Price-to-Fair Value
5.96 4.43 5.08 4.33 4.02
Enterprise Value Multiple
65.17 11.43 14.41 9.94 23.87
EV to EBITDA
65.17 11.43 14.41 9.94 23.87
EV to Sales
3.77 4.43 4.68 4.12 4.00
EV to Free Cash Flow
10.51 16.17 15.29 10.42 13.12
EV to Operating Cash Flow
10.00 14.99 14.06 9.89 12.08
Tangible Book Value Per Share
-7.23 -9.63 -12.75 -16.50 -18.31
Shareholders’ Equity Per Share
15.50 18.30 16.90 16.77 14.50
Tax and Other Ratios
Effective Tax Rate
0.31 0.18 0.21 0.25 0.95
Revenue Per Share
23.06 21.73 21.74 21.74 19.64
Net Income Per Share
0.38 4.54 3.66 4.96 0.07
Tax Burden
0.70 0.83 0.79 0.75 0.05
Interest Burden
0.41 0.88 0.86 0.89 0.63
Research & Development to Revenue
0.21 0.26 0.18 0.20 0.20
SG&A to Revenue
0.00 0.19 0.18 0.17 0.18
Stock-Based Compensation to Revenue
0.03 0.03 0.02 0.02 0.03
Income Quality
22.56 1.43 1.99 1.84 91.78
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis